Advisor Group’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$9K Sell
2,653
-105
-4% -$362 ﹤0.01% 4409
2019
Q3
$10K Buy
2,758
+2
+0.1% +$9 ﹤0.01% 4330
2019
Q2
$12K Sell
2,756
-32
-1% -$128 ﹤0.01% 4254
2019
Q1
$10K Sell
2,788
-125
-4% -$416 ﹤0.01% 4368
2018
Q4
$6K Buy
2,913
+544
+23% +$2.24K ﹤0.01% 4422
2018
Q3
$16K Buy
2,369
+100
+4% +$710 ﹤0.01% 4015
2018
Q2
$17K Hold
2,269
﹤0.01% 3795
2018
Q1
$16K Sell
2,269
-1,705
-43% -$12.6K ﹤0.01% 3811
2017
Q4
$30K Sell
3,974
-238
-6% -$1.98K ﹤0.01% 3431
2017
Q3
$35K Sell
4,212
-25
-0.6% -$156 ﹤0.01% 3189
2017
Q2
$19K Sell
4,237
-10,973
-72% -$44K ﹤0.01% 3519
2017
Q1
$59K Sell
15,210
-700
-4% -$2.77K ﹤0.01% 2577
2016
Q4
$64K Sell
15,910
-200
-1% -$816 ﹤0.01% 2409
2016
Q3
$74K Sell
16,110
-1,646
-9% -$8.47K ﹤0.01% 2228
2016
Q2
$84K Buy
+17,756
New +$101K ﹤0.01% 2047

Other funds holding CLMT

Advisor Group's CLMT Position: Q4 2019 in Review

Advisor Group reduced its Calumet Specialty Products (CLMT) stake by 3.8% in Q4 2019, selling an estimated $362 and leaving 2,653 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4409.

Advisor Group first reported a position in CLMT in Q2 2016 and has held it in 15 quarters since. The position peaked at $84K in Q2 2016. 62 funds tracked by Wall St. Rank hold CLMT as of Q4 2019.

  • Advisor Group held 2,653 shares of Calumet Specialty Products worth $9K as of Q4 2019.
  • Advisor Group sold 105 Calumet Specialty Products shares in Q4 2019, an estimated $362.
  • Calumet Specialty Products made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4409 holding.
  • Advisor Group first reported a position in Calumet Specialty Products in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Calumet Specialty Products position peaked at $84K in Q2 2016.
  • 62 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.